| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |